Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.
SCOTTS MIRACLE-GRO CO (SMG) reported revenue of $1.17B and net income of $112.20M for the fiscal year ended 2026-06-27. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from SCOTTS MIRACLE-GRO CO’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Agricultural Chemicals.
Income
| Metric | 2026-06-27 | 2026-03-28 | 2025-12-27 | 2025-09-30 | 2025-06-28 | 2025-03-29 | 2024-12-28 | 2024-09-30 | 2024-06-29 | 2024-03-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.17B | $1.46B | $354.40M | $497.40M | $1.16B | $1.39B | $366.60M | $414.70M | $1.20B | $1.53B |
| Cost of revenue | $805.00M | $849.00M | $264.40M | $444.80M | $784.60M | $842.30M | $276.70M | $427.30M | $850.60M | Unavailable |
| Gross profit | $365.90M | $610.50M | $88.70M | $40.90M | $372.70M | $542.10M | $88.50M | -$29.50M | $354.10M | Unavailable |
| Operating income | $169.60M | $401.80M | -$21.80M | -$167.10M | $221.80M | $349.70M | -$45.80M | -$216.10M | $200.10M | $272.10M |
| Net income | $112.20M | $238.60M | -$125.00M | -$151.90M | $149.10M | $217.50M | -$69.50M | Unavailable | Unavailable | Unavailable |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 59.20M | shares 59.10M | shares 57.90M | Unavailable | shares 58.60M | shares 58.40M | shares 57.30M | Unavailable | shares 58.00M | shares 57.40M |
| Pretax income | $155.20M | $364.90M | -$63.30M | -$207.40M | $214.00M | $306.00M | -$90.90M | -$312.20M | $183.00M | $219.80M |
| Income tax expense | $51.60M | $101.60M | -$15.50M | -$43.20M | $59.30M | $85.30M | -$24.80M | -$68.20M | $50.90M | $62.30M |
| Diluted EPS | $1.90 | $4.04 | $-2.16 | Unavailable | $2.54 | $3.72 | $-1.21 | Unavailable | $2.28 | $2.74 |
| Selling, general & administrative | $145.60M | $199.20M | $106.00M | $167.20M | $144.80M | $177.80M | $113.50M | $117.60M | $147.90M | $178.70M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-27 | 2026-03-28 | 2025-12-27 | 2025-09-30 | 2025-06-28 | 2025-03-29 | 2024-12-28 | 2024-09-30 | 2024-06-29 | 2024-03-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $27.70M | $6.20M | $8.30M | $32.80M | $39.60M | $8.70M | $5.70M | $71.60M | $279.90M | $65.10M |
| Total assets | $3.17B | $3.41B | $3.03B | $2.74B | $3.09B | $3.54B | $3.17B | $2.87B | $3.49B | $3.92B |
| Current assets | $1.35B | $1.62B | $1.26B | $940.30M | $1.28B | $1.73B | $1.29B | $980.40M | $1.54B | $1.94B |
| Total liabilities | $3.38B | $3.70B | $3.53B | $3.10B | $3.26B | $3.83B | $3.65B | $3.26B | $3.64B | $4.18B |
| Current liabilities | $1.11B | $1.28B | $932.40M | $739.70M | $798.60M | $1.01B | $683.80M | $750.30M | $854.40M | $1.06B |
| Total equity incl. NCI | -$208.70M | -$286.50M | -$500.60M | -$357.50M | -$170.90M | -$290.10M | -$479.50M | -$390.60M | -$146.20M | -$250.90M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $481.40M | $696.00M | $846.70M | $542.70M | $485.40M | $709.60M | $844.90M | $587.50M | $606.80M | $824.30M |
| Accounts receivable | $713.00M | $766.70M | $193.80M | $160.80M | $545.70M | $767.80M | $173.00M | $176.80M | $504.60M | $876.90M |
| Goodwill | $243.90M | $243.90M | $243.90M | $243.90M | $243.90M | $243.90M | $243.90M | $243.90M | $243.90M | $243.90M |
| Long-term debt | $1.84B | $2.07B | $2.25B | $2.05B | $2.14B | $2.49B | $2.64B | $2.17B | $2.44B | $2.76B |
| Accounts payable | $310.30M | $385.80M | $283.90M | $221.40M | $246.30M | $382.60M | $284.40M | $254.70M | $316.70M | $440.40M |
Cash flow
| Metric | 2026-06-27 | 2026-03-28 | 2025-12-27 | 2025-09-30 | 2025-06-28 | 2025-03-29 | 2024-12-28 | 2024-09-30 | 2024-06-29 | 2024-03-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $345.60M | $220.00M | -$370.40M | $174.10M | $454.40M | $188.10M | -$445.30M | $118.50M | $588.00M | $304.20M |
| Capital expenditures | $24.50M | $18.60M | $20.00M | $42.90M | $16.90M | $8.30M | $29.30M | $16.60M | $13.20M | $16.30M |
| Investing cash flow | -$56.70M | -$23.60M | -$21.80M | -$52.10M | -$25.30M | -$11.40M | -$23.30M | -$20.40M | -$8.90M | -$17.90M |
| Financing cash flow | -$270.00M | -$198.60M | $366.80M | -$135.80M | -$396.10M | -$169.80M | $407.70M | -$306.80M | -$363.90M | -$231.40M |
| Net change in cash | $18.60M | -$2.20M | -$25.30M | -$14.50M | $34.20M | $7.10M | -$61.80M | -$208.30M | $214.80M | $54.70M |
| Stock-based compensation | $12.00M | $18.90M | $7.40M | $13.40M | $17.50M | $22.60M | $15.50M | $14.70M | $21.10M | $28.60M |
| Common dividends paid | $38.50M | $39.50M | $38.30M | $38.10M | $38.20M | $38.80M | $39.20M | $37.60M | $37.50M | $38.80M |
| Common share repurchases | $500.00K | $3.30M | $8.30M | $0 | $100.00K | $2.70M | $15.60M | $100.00K | $100.00K | $1.80M |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2026-06-27 | 2026-03-28 | 2025-12-27 | 2025-09-30 | 2025-06-28 | 2025-03-29 | 2024-12-28 | 2024-09-30 | 2024-06-29 | 2024-03-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $321.10M | $201.40M | -$390.40M | $131.20M | $437.50M | $179.80M | -$474.60M | $101.90M | $574.80M | $287.90M |
| Gross margin | 31.2% | 41.8% | 25.0% | 8.2% | 32.1% | 39.0% | 24.1% | -7.1% | 29.5% | Unavailable |
| Operating margin | 14.5% | 27.5% | -6.2% | -33.6% | 19.1% | 25.2% | -12.5% | -52.1% | 16.6% | 17.8% |
| FCF margin | 27.4% | 13.8% | -110.2% | 26.4% | 37.7% | 12.9% | -129.5% | 24.6% | 47.8% | 18.9% |
| SBC / revenue | 1.0% | 1.3% | 2.1% | 2.7% | 1.5% | 1.6% | 4.2% | 3.5% | 1.8% | 1.9% |
| Current ratio | 1.21x | 1.27x | 1.35x | 1.27x | 1.61x | 1.71x | 1.88x | 1.31x | 1.80x | 1.83x |
| Revenue YoY growth | 1.1% | 5.0% | -3.3% | 19.9% | -3.6% | -8.9% | -10.7% | 10.7% | 7.5% | -0.4% |
| Net margin | 9.6% | 16.3% | -35.3% | -30.5% | 12.9% | 15.7% | -19.0% | Unavailable | Unavailable | Unavailable |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 2.1% | 1.3% | 5.6% | 8.6% | 1.5% | 0.6% | 8.0% | 4.0% | 1.1% | 1.1% |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 33.2% | 27.8% | Unavailable | Unavailable | 27.7% | 27.9% | Unavailable | Unavailable | 27.8% | 28.3% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SMG in the interactive workspace to inspect any figure back to its filing.
Source filings
Reconciliation checks needing review
3 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.
Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.